Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment
Top Cited Papers
Open Access
- 6 June 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 53 (12), 2143-2154
- https://doi.org/10.1093/rheumatology/keu224
Abstract
Risk of cardiovascular (CV) disease is increased among RA patients. High inflammatory burden associated with RA appears to be a key driver of the increased cardiovascular risk. Inflammation is linked with accelerated atherosclerosis and associated with a paradoxical inversion of the relationship between CV risk and lipid levels in patients with untreated RA, recently coined the lipid paradox. Furthermore, the inflammatory burden is also associated with qualitative as well as quantitative changes in lipoproteins, with the anti-inflammatory and atheroprotective roles associated with high-density lipoprotein cholesterol significantly altered. RA therapies can increase lipid levels, which may reflect the normalization of lipids due to their inflammatory-dampening effects. However, these confounding influences of inflammation and RA therapies on lipid profiles pose challenges for assessing CV risk in RA patients and interpretation of traditional CV risk scores. In this review we examine the relationship between the increased inflammatory burden in RA and CV risk, exploring how inflammation influences lipid profiles, the impact of RA therapies and strategies for identifying and monitoring CV risk in RA patients aimed at improving CV outcomes.Keywords
This publication has 136 references indexed in Scilit:
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studiesThe Lancet, 2012
- Proteomic profiling following immunoaffinity capture of high‐density lipoprotein: Association of acute‐phase proteins and complement factors with proinflammatory high‐density lipoprotein in rheumatoid arthritisArthritis & Rheumatism, 2012
- Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritisArthritis & Rheumatism, 2011
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2009
- Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritisArthritis Care & Research, 2009
- Cardiovascular Morbidity and Mortality in Rheumatoid ArthritisAmerican Journal Of Medicine, 2008
- Inflammation‐associated insulin resistance: Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanismsArthritis & Rheumatism, 2008
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trialThe Lancet, 2008
- Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics RegisterArthritis & Rheumatism, 2007
- Cardiovascular death in rheumatoid arthritis: A population‐based studyArthritis & Rheumatism, 2005